Continuing Professional Development

The ECPM Continuing Professional Development (CPD) platform provides accredited high quality educational programs to support continuing medical education and professional development for physicians, and pharmaceutical industry, regulatory and university professionals. As such, its primary intention is to provide up-to-date knowledge on current trends in drug development and to train drug development professionals for their next career step. Additionally, it offers a platform to share knowledge with colleagues and discuss with experts face-to-face. Our services include a broad range of CPD short courses that cover all skills across the drug development process. These CPD short courses count towards the Master program, yet they are also a stand-alone offer and can be booked individually to shape your professional skills and are offered in the following formats:

Short Courses/Workshops - A range of interactive onsite short courses/workshops. These cover a broad curriculum within the drug development process - from educational seminars to soft skills.

Frontiers in Drug Development Seminar - One day onsite seminars on new trends in drug development science.

E-Learning -Selected e-learning courses that provide an interactive environment for self-paced learning and can be booked at any time.

Study Trips - Yearly international study trips. A total of six study half-days are planned, which allow participants to experience a mix of theory and visits to institutions.

Courses offered by other Course Providers - Co-organized courses with other institutions, such as the University Hospital of Basel or partner universities. In addition, students also have the opportunity to choose courses offered by PharmaTrain Recognized Course Providers.

If you are interested in receiving information about our courses please subscribe to our ECPM newsletter.

ECPM Presentation and communicationSkill
26.10.2021 08:00

Communicating more powerfully and persuasively

More Information

Course Description

This course is an intense two-day interactive, hands-on program designed to build and expand essential presentation skills from both content and delivery perspectives. Participants will learn how to improve their personal communication skills, their ability to develop targeted, compelling and memorable presentations, and to handle difficult questions from stakeholders.

Participants should come ready to deliver a ten-minute presentation as well as a short story about a project in which they have been involved. Crucially, the story must include the type of obstacles that were faced, how they were overcome, the people or factors that helped or hindered along the way, together with the successes and failures and the outcome. Feedback from peers and the facilitators will help participants improve their ability to connect from both content and delivery perspectives.

Course Program

Day 1 – The process, establishing a baseline, stakeholders and messaging

  • Introduction to developing powerful presentations
  • Participants will deliver two presentations and receive direct feedback
  • Stakeholder definition, prioritization and analysis
  • Development of key messages

Day 2 – Storytelling, creating a narrative, and Q&A

  • Storytelling techniques
  • Structure and storyboard a presentation to address key stakeholders
  • Media techniques to confidently handle question and answer sessions
  • Delivery of final presentations by participants

Learning Outcomes

By the end of the course, participants will have a better understanding of how to:

  • Present in a more compelling way to internal and external stakeholders with increased confidence and capability
  • Use skills and techniques to:
    • Translate complex concepts into scalable and tailored messages for stakeholders
    • Develop engaging narratives using storytelling models that showcase and differentiate their science/project
    • Speak effectively to groups of any size face-to-face and online
    • Confidently handle question and answer sessions

Course Faculty

O’Patrick Wilson and Jennifer Sgueglia, O public relations GmbH, Ettingen, Switzerland

Target Audience

The course is designed for participants who want to improve their personal communication skills, their ability to develop targeted, compelling and memorable presentations, and to handle difficult questions from stakeholders.

Course Language

English

    Course Credits

    The course including assessment provides 2 ECTS credits. The course is accredited with 100 FPH-points in hospital pharmacy by the Swiss Society FPH Spital (Fachgesellschaft FPH Spital).

    Course Date and Venue

    October 26-27, 2021
    University of Basel

    Course Fee

    Course fee including certificate, electronic course material and coffee breaks is CHF 1800.
    A reduced fee applies to participants from academia and nonprofit organizations.

    Cancellation Policy

    Refund of fee will be given if cancellation is received in written format () before the deadline for registration, after this date no refund can be given.

    Deadline for Registration

    October 18, 2021

    Course Organizer

    This course is organized by the European Center of Pharmaceutical Medicine.

    Registration
    01.12.2021 11:45

    CAS Klinisch-genomische Medizin & Einführung in das Genetic Counseling - Mai bis Dezember 2021

    More Information

    Kursbeschreibung

    Die rasanten Fortschritte der molekularen Medizin beeinflussen immer mehr klinische Disziplinen und zwingen die Leistungserbringer, sich vermehrt mit diesen Themen auseinanderzusetzen. Auch Patientinnen und Patienten konfrontieren die Ärzte- und Apothekerschaft zunehmend mit Fragen zu genetischen Tests. Letztendlich wollen auch sie erfahren, welchen Einfluss die molekulare Medizin auf den klinischen  Entscheidungsprozess hat.

    Im Zertifikatskurs «Klinisch-genomische Medizin: Genetic Counseling» werden in komprimierter Art und Weise die wichtigsten Grundlagen der genomischen und personalisierten Medizin durch ausgewiesene Experten vermittelt. Die Teilnehmenden lernen, die Erkenntnisse molekularer Möglichkeiten klinisch einzuordnen und erfahren Wissenswertes über die zukünftigen und aussichtsreichsten  Anwendungsgebiete dieser faszinierenden Technologien.

    Modul A: Grundlagen der genomischen Medizin
    Modul B: Klinische Anwendungen der genomischen Medizin
    Modul C: Personalisierte Medizin und Public Health Genomics


    Weitere Informationen

    Leitung und Organisation
    Kursdetails und Teilnahmegebühren
    Lehrveranstaltungsplan

    Termine

    • Lehrveranstaltungsblock A1: Donnerstag - Samstag, 27. - 29. Mai 2021 Unterrichtzeit: 8.30 – 17.30 Uhr
    • Lehrveranstaltungsblock A2: Donnerstag - Samstag, 24. - 26. Juni 2021 Unterrichtzeit: 8.30 – 17.30 Uhr
    • Lehrveranstaltungsblock B1: Freitag - Samstag, 20. - 21. August 2021 Unterrichtzeit: 8.30 – 17.30 Uhr
    • Lehrveranstaltungsblock B2: Donnerstag - Samstag, 23. - 25. September 2021 Unterrichtzeit: 8.30 – 17.30 Uhr
    • Lehrveranstaltungsblock C1: Donnerstag - Samstag, 21. -23. Oktober 2021 Unterrichtzeit: 8.30 – 17.30 Uhr / Basel
    • Lehrveranstaltungsblock C2: Freitag - Samstag, 19. - 20. November 2021 Unterrichtzeit: 8.30 – 17.30 Uhr
    • Lehrveranstaltungsblock B3: Donnerstag - Samstag, 03. - 04. Dezember 2021 Unterrichtzeit: 8.30 – 17.30 Uhr

    Kontakt

    Private Universität im Fürstentum Lichtenstein
    Margot Hermann
    weiterbildung@ufl.li
    +423 392 40 10

    ECPM Clinical Trial
    07.12.2021 08:00

    DAS Clinical Trial Practice and Management - December 2021 or February 2022 until 2023

    More Information

    Course Description

    Successful clinical research requires clinical experience, but also extensive knowledge about all phases of the clinical research process, awareness of regulatory requirements as well as project management and leadership skills. The complex and highly competitive nature of clinical research, results in a growing need for well-trained clinical research professionals, not least those working as study coordinators, study managers, clinical monitors or clinical research assistants.

    Clinical research professionals usually start their careers with background knowledge from diverse graduate training often lacking structured training in clinical research. Still, they are facing highly demanding responsibilities in a complex, ever-evolving, interdisciplinary and often multinational environment. Fortunately, training at the postgraduate level is increasingly being recognized as essential to developing scientific, technical and interpersonal competencies to ultimately enhance the quality of clinical research.

    The goal of this program is to prepare trainees for the variety of management and leadership roles in different clinical research settings such as academia, pharmaceutical, medical device or biotech industry, clinical research organizations and regulatory agencies.

    Course Organizer and Registration

    This course is organized by the CTU Clinical Trial Unit, University Hospital of Basel.
    Course details and registration
     

     

    01.11.2022 08:00

    Ethical and Legal Aspects of Clinical Trials

    More Information

    Course Description

    The implementation of clinical research projects requires conscientious review of research projects not only in terms of their scientific quality but also in regard to their ethical adequacy and appropriateness. How can we balance the risk-benefit of our projects? Given the importance of ethics for the conduct of drug development and research, it should come as no surprise that many different professional associations, government agencies, and universities have adopted specific codes, rules, and policies relating to research ethics.

    Each of these aspects will be carefully considered and discussed in the context of international and national principles and guidelines. These issues need to be carefully adhered to strengthen the health of the clinical trial enterprise to the benefit of patients and the overall health of the public. During our course, representatives from different institutions will introduce and discuss the most important concepts, tools, principles, and methods that can be useful in approaching and resolving ethical dilemmas. Realworld examples and case studies will be introduced and discussed.

    Course Program

    Day 1
    The Evolution of Biomedical Research Ethics / Risk-Benefit Considerations of Research Interventions / Role of Ethics Committees / Successful Submission to an Ethics Committee / Coordinating Human Research in Switzerland / How to Design an Informed Consent / Ethical Review Systems in Europe and European Legislation / Ethics Committees’ Role in Reviewing Safety Information

    Day 2
    Equipoise / Transparency in Clinical Trials / Common Technical Document / Confidentiality and Intellectual Property / Personal Data Protection / Inducement in Clinical Research – from Recruitment Advertisement to Subject Compensation / Role of Patient Organisations in Clinical Trials (EUPATI) / Public Health Ethics (incl. biobanks)

    Day 3
    Ethical Aspects of Clinical Research in Children / Informed Consent Process in Pediatric Patients / Clinical Research in Vulnerable Populations / Misconduct and Fraud, Research Integrity / ICH E6 Regulation / Legal and Ethical Framework for Genetic Testing

    Learning Outcomes

    By the end of the course, students will be able to:

    • Name key principles of ethical considerations during clinical research and development
    • Discuss ethical concerns for designing, conducting and reporting the results obtained through the conduct of clinical trials
    • Understand international and national principles and guidelines which have to be followed when performing clinical trials

    Course Faculty

    Dr. Jane Barrett
    Dr. Julia Bielicki
    Dr. Corina Braem
    Dr. Thomas Gruberski
    Nienke Jones
    Dr. Peter Kleist
    Dr. Ingrid Klingmann
    Dr. Sabine Österle
    Dr. Nicole Probst
    Magalie Wasem-Tréguer
    Dr. Beat Widler

    Target Audience

    All pharmaceutical and health care professionals who are interested in getting a deeper understanding of ethical and legal aspects in medicines development.

    Course Language

    English

    Course Credits

    The course including assessment provides 2 ECTS credits.

    Course Date and Venue

    Will be announced for November 2022.

    Course Fee

    Course fee including certificate, electronic course material and coffee breaks is CHF 2000.
    A reduced fee applies to participants from academia and nonprofit organizations.

    Cancellation Policy

    Refund of fee will be given if cancellation is received in written format () before the deadline for registration, after this date no refund can be given.

    Deadline for Registration

    Will be announced for November 2022.

    Course Organizer

    This course is organized by the European Center of Pharmaceutical Medicine.

    ECPM European University Network
    ECPM partner universities in the European University Network
    01.01.2023 08:10

    Other Courses by Pharmatrain

    More Information

    Join courses run by our partner universities in the European University Network, which offer training relevant to drug development sciences and the IMI PharmaTrain syllabus. For an overview of all PharmaTrain Recognized Course Providers please click here.

    E-Learning: Basics in Health Economics

    More Information

    Course Description

    This e-learning course provides an understanding of the key principles and methodological concepts of health economic evaluations. It is based on the well-established face-to-face course on health economics offered by the ECPM. The scientific content was developed by Prof. Thomas Szucs and Prof. Matthias Schwenkglenks as well as other specialists from the field.

    Learning Outcomes

    At the end of the course, the participants should be able to describe:

    • Fundamental concepts of health economics
    • Key elements of health economic evaluation
    • Assessment and analysis of a published health economic study
    • The importance of health economic/pharmacoeconomic methods and concepts for the drug development process, clinical trials, and post-marketing surveillance
    • How policymakers set priorities in health care and how health economic evaluations support this process

    Structure and Workload

    Our e-learning courses provide an interactive environment for self-paced learning. As soon as you have booked the course, the program is accessible online for you during one year at anytime. The course allows you to start/stop at any time. There will be several intermediate tests which will prepare you for the final test. The curriculum consists of nine lessons with a duration of approximately 60 to 90 minutes each. In addition, individual study, such as critical appraisal of specific literature is required (in total: approximately 30 hours). Each lesson is aimed to achieve a set of learning outcomes, using interactive techniques to help reinforce the taught topics.

    Course Language

    English

    Course Credits

    After successful completion of the e-learning course, 1 ECTS will be awarded (Certificate of Attendance from the University of Basel).

    Course Fee

    CHF 650
    A reduced fee applies to participants from academia and nonprofit organizations.

    Course Organizer

    This course is organized by the European Center of Pharmaceutical Medicine.

    Registration

    E-learning: Drug Safety and Pharmacovigilance

    More Information

    Course Description

    This e-learning course provides an understanding of the safety-related aspects within the drug development process. These range from early preclinical testing, risk/benefit assessment up to clinical adverse event signal detection and monitoring.

    Learning Outcomes

    At the end of the course, the participants should be able to describe:

    • The role of drug safety in the successful development and usage of a medicine to the benefit of patients
    • Which safety-related questions need to be answered in early and late drug development
    • Tools, techniques, and methodologies used in drug safety evaluation
    • What frequent pitfalls related to drug safety considerations occur and why they can lead to discontinuation of drugs in development, label changes or even withdrawal of drugs from the market after launch
    • How changes in safety assessment could become part of a new drug development paradigm

    Structure and Workload

    Our e-learning courses provide an interactive environment for self-paced learning. As soon as you have booked the course, the program is accessible online for you during one year at anytime. The course allows you to start/stop at any time. There will be several intermediate tests which will prepare you for the final test. The curriculum consists of nine lessons with a duration of approximately 60 to 90 minutes each. In addition, individual study, such as critical appraisal of specific literature is required (in total: approximately 30 hours). Each lesson is aimed to achieve a set of learning outcomes, using interactive techniques to help reinforce the taught topics.

    Course Language

    English

    Course Credits

    After successful completion of the e-learning course, 1 ECTS will be awarded (Certificate of Attendance from the University of Basel).

    Course Fee

    CHF 650
    A reduced fee applies to participants from academia and nonprofit organizations.

    Course Organizer

    This course is organized by the European Center of Pharmaceutical Medicine.

    Registration

    E-Learning: Personalized Health Care

    More Information

    Course Description

    This e-learning course provides an understanding of the key principles and methodological concepts of personalized drug development. The role of individualized treatment strategies is addressed, including all relevant clinical, ethical and governmental aspects.

    Learning Outcomes

    At the end of the course, the participants should be able to:

    • Understand the biological and clinical concepts of personalized medicine
    • Understand the benefits and pitfalls of individualized therapies for patients
    • Comprehend the basic elements of predictive and prognostic interventions
    • Understand the role of surrogate endpoints and clinically validated biomarkers in personalized medicine
    • Understand pharmacogenetic and pharmacogenomic implications
    • Be aware of the strategies of R&D processes with personalized drugs
    • Understand the economics challenges of personalized medicine and how policymakers set priorities in individualized health care
    • Determine legal, regulatory and ethical aspects of personalised medicine

    Structure and Workload

    Our e-learning courses provide an interactive environment for self-paced learning. As soon as you have booked the course, the program is accessible online for you during one year at anytime. The course allows you to start/stop at any time. There will be several intermediate tests which will prepare you for the final test. The curriculum consists of nine lessons with a duration of approximately 60 to 90 minutes each. In addition individual study, such as critical appraisal of specific literature is required (in total: approximately 30 hours). Each lesson is aimed to achieve a set of learning outcomes, using interactive techniques to help reinforce the taught topics.

    Course Language

    English

    Course Credits

    After successful completion of the e-learning course, 1 ECTS will be awarded (Certificate of Attendance from the University of Basel).

    Course Fee

    CHF 650
    A reduced fee applies to participants from academia and nonprofit organizations.

    Course Organizer

    This course is organized by the European Center of Pharmaceutical Medicine.

    Registration